Home/Publication/Crescent Capital’s ACL Withdraws Takeover of Healius
Crescent Capital’s ACL Withdraws Takeover of Healius 

01 Jan 2024

US$ 19.00

Australian Clinical Labs Ltd (ACL), backed by Crescent Capital Partners (Crescent), failed to receive the green light...

Price / article: US$19.00
OR existing subscriber
Related Publications

US-based Accel-KKR has reportedly acquired Health Metrics Pty Ltd (Health Metrics) from Tanarra Capital Partners...

Circle Internet Group Inc (Circle), backed by IDG Capital (IDG), was listed on the New York Stock Exchange and raised...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.